<DOC>
	<DOC>NCT02877069</DOC>
	<brief_summary>This study will evaluate the safety and effectiveness of VYC-12 hyaluronic acid (HA) injectable gel for filling fine lines, as measured by skin texture improvement, and for improvement of skin quality.</brief_summary>
	<brief_title>Safety and Effectiveness of VYC-12 Hyaluronic Acid Injectable Gel for Treatment of Superficial Cutaneous Depressions</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>Participants in good general health Score of 2=Moderate (coarse and uneven visual skin texture) or 3=Severe (coarse visual skin texture, crosshatched fine lines) on both cheeks using the 5Point Allergan Skin Roughness Scale (ASRS). Has undergone tissue augmentation with dermal fillers including HA, calcium hydroxylapatite, autologous fat, mesotherapy, or other cosmetic procedures (eg. facelift, laser, photomodulation, intense pulsed light, radiofrequency, dermabrasion, chemical peel, or other ablative procedures) in the face or neck within the past 12 months Has received any crosslinked HA filler in any anatomic area within the past 12 months Has undergone treatment with botulinum toxins in the face or neck within the past 6 months Has ever received semipermanent fillers or permanent facial implants (eg. polyLlactic acid, polymethylmethacrylate, silicone, expanded polytetrafluoroethylene) anywhere in the face or neck Has facial hair that would interfere with the visualization of the face or neck Has undergone a dental procedure within the past 6 weeks Has a tendency to develop hypertrophic scarring Has a history of allergy to HA products and/or to grampositive bacterial proteins as HA is produced by Streptococcustype bacteria Has a history of anaphylactic shock Has been previously diagnosed with streptococcal disease (eg. recurrent sore throat, acute rheumatic fever) Has current cutaneous inflammatory or infectious processes (eg. acne, herpes), abscess, an unhealed wound, or a cancerous or precancerous lesion on the face or neck Is on an ongoing regimen of anticoagulation therapy (eg. warfarin) Is on an ongoing regimen of medications (eg. aspirin, ibuprofen) or other substances (eg, herbal supplements with garlic, gingko biloba, or ginseng) known to increase coagulation time within 10 days of undergoing study device injection Has begun using any overthecounter or prescription, oral or topical, antiwrinkle products on the face or neck within the past 30 days.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>